Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:19620548" >
Toll-like receptor ...
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses
-
- Lore, K (författare)
- Karolinska Institutet
-
Betts, MR (författare)
-
Brenchley, JM (författare)
-
visa fler...
-
Kuruppu, J (författare)
-
Khojasteh, S (författare)
-
Perfetto, S (författare)
-
Roederer, M (författare)
-
Seder, RA (författare)
-
Koup, RA (författare)
-
visa färre...
-
(creator_code:org_t)
- The American Association of Immunologists, 2003
- 2003
- Engelska.
-
Ingår i: Journal of immunology (Baltimore, Md. : 1950). - : The American Association of Immunologists. - 0022-1767 .- 1550-6606. ; 171:8, s. 4320-4328
- Relaterad länk:
-
http://www.jimmunol....
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.4...
-
visa färre...
Abstract
Ämnesord
Stäng
- Optimal Ag targeting and activation of APCs, especially dendritic cells (DCs), are important in vaccine development. In this study, we report the effects of different Toll-like receptor (TLR)-binding compounds to enhance immune responses induced by human APCs, including CD123+ plasmacytoid DCs (PDCs), CD11c+ myeloid DCs (MDCs), monocytes, and B cells. PDCs, which express TLR7 and TLR9, responded to imidazoquinolines (imiquimod and R-848) and to CpG oligodeoxynucleotides stimulation, resulting in enhancement in expression of costimulatory molecules and induction of IFN-α and IL-12p70. In contrast, MDCs, which express TLR3, TLR4, and TLR7, responded to poly(I:C), LPS, and imidazoquinolines with phenotypic maturation and high production of IL-12 p70 without producing detectable IFN-α. Optimally TLR ligand-stimulated PDCs or MDCs exposed to CMV or HIV-1 Ags enhanced autologous CMV- and HIV-1-specific memory T cell responses as measured by effector cytokine production compared with TLR ligand-activated monocytes and B cells or unstimulated PDCs and MDCs. Together, these data show that targeting specific DC subsets using TLR ligands can enhance their ability to activate virus-specific T cells, providing information for the rational design of TLR ligands as adjuvants for vaccines or immune modulating therapy.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas